Treosulfan-Based Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Other Myeloid Malignancies

<b>Background:</b> Treosulfan combined with fludarabine (FluTreo) has emerged as a reduced-toxicity alternative to conventional myeloablative conditioning in allogeneic hematopoietic cell transplantation (allo-HCT) for acute myeloid leukemia (AML) and related myeloid malignancies. <b>Purpose:</b> Th...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Eleni Gavriilaki, Panagiotis Dolgyras, Ioannis Konstantinidis, Despina Mallouri, Grigorios Salvaras, Christos Demosthenous, Ioannis Batsis, Anna Vardi, Ioannis Papadopoulos, Sophia Tsokkou, Zoi Bousiou, Giorgos Karavalakis, Christos Varelas, Alkistis Panteliadou, Nikolaos Spyridis, Antonia Syrigou, Anastasia Marvaki, Maria Papathanasiou, Apostolia Papalexandri, Chrysavgi Lalayanni, Chrysanthi Vadikoliou, Anastasia Athanasiadou, Ioanna Sakellari
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2025-10-01
Serie:	Pharmaceuticals
Soggetti:	allogeneic hematopoietic cell transplantation (allo-HCT) treosulfan reduced-toxicity conditioning acute myeloid leukemia (AML) myelodysplastic syndrome (MDS) myelofibrosis (MF)
Accesso online:	https://www.mdpi.com/1424-8247/18/11/1631
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!